Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

Hyeong Kyu Park,Kyoung-Ah Kim,Kyung-Wan Min,Tae-Seo Sohn,In Kyung Jeong,Chul Woo Ahn,Nan-Hee Kim,Ie Byung Park,Ho Chan Cho,Choon Hee Chung,Sung Hee Choi,Kang Seo Park, Seoung-Oh Yang,Kwan Woo Lee

Diabetes, obesity & metabolism（2023）

引用 0|浏览8

暂无评分

摘要

Dapagliflozin reduced total BF mass, abdominal VAT and SAT areas, and showed better glycaemic control than glimepiride. Being safe and well-tolerated, dapagliflozin appears to be a more favourable alternative to sulphonylureas as add-on therapy after metformin monotherapy failure in Korean patients with type 2 diabetes.

查看译文

关键词

metformin,diabetes,dapagliflozin,asian patients,glimepiride

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要